Home > Compound List > Compound details
147025-53-4 molecular structure
click picture or here to close

(3R)-3-(prop-2-yn-1-yloxy)-1-azabicyclo[2.2.2]octane

ChemBase ID: 129692
Molecular Formular: C10H15NO
Molecular Mass: 165.2322
Monoisotopic Mass: 165.11536411
SMILES and InChIs

SMILES:
O([C@@H]1C2CCN(CC2)C1)CC#C
Canonical SMILES:
C#CCO[C@H]1CN2CCC1CC2
InChI:
InChI=1S/C10H15NO/c1-2-7-12-10-8-11-5-3-9(10)4-6-11/h1,9-10H,3-8H2/t10-/m0/s1
InChIKey:
XVFJONKUSLSKSW-JTQLQIEISA-N

Cite this record

CBID:129692 http://www.chembase.cn/molecule-129692.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
(3R)-3-(prop-2-yn-1-yloxy)-1-azabicyclo[2.2.2]octane
IUPAC Traditional name
talsaclidine
Synonyms
Talsaclidine
(R)-3-(2-Propynyloxy)-1-azabicyclo[2.2.2]octane
CAS Number
147025-53-4
PubChem SID
162223981
PubChem CID
71792
Chemspider ID
64819
Unique Ingredient Identifier
1O8VSL798T
Wikipedia Title
Talsaclidine

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID Price
TRC
T005600 external link Add to cart Please log in.

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
H Acceptors H Donor
LogD (pH = 5.5) -2.3355896  LogD (pH = 7.4) -0.64793724 
Log P 0.7282815  Molar Refractivity 48.563 cm3
Polarizability 18.811037 Å3 Polar Surface Area 12.47 Å2
Rotatable Bonds Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Physical Property Safety Information Pharmacology Properties Product Information Bioassay(PubChem)
Solubility
Dichloromethane expand Show data source
Ethyl Acetate expand Show data source
Apperance
Brown Oil expand Show data source
MSDS Link
Download expand Show data source
Bioavailability
70% expand Show data source
Excretion
Renal (86%) expand Show data source
Protein Bound
7% expand Show data source
Certificate of Analysis
Download expand Show data source

DETAILS

DETAILS

Wikipedia Wikipedia TRC TRC
Toronto Research Chemicals - T005600 external link
Talsaclidine, a novel M1-receptor selective muscarinic agonist for cholinergic substitution therapy of Alzheimer's disease. Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • Hock, et al.: Amyloid, 10(1)
  • • 1 (1)
  • • Moreau, M., et al.: J. Pharmacol. Sci., 99, 6 (1)
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle